182 related articles for article (PubMed ID: 27127878)
1. FXR agonists enhance the sensitivity of biliary tract cancer cells to cisplatin via SHP dependent inhibition of Bcl-xL expression.
Wang W; Zhan M; Li Q; Chen W; Chu H; Huang Q; Hou Z; Man M; Wang J
Oncotarget; 2016 Jun; 7(23):34617-29. PubMed ID: 27127878
[TBL] [Abstract][Full Text] [Related]
2. Phenylethyl isothiocyanate reverses cisplatin resistance in biliary tract cancer cells via glutathionylation-dependent degradation of Mcl-1.
Li Q; Zhan M; Chen W; Zhao B; Yang K; Yang J; Yi J; Huang Q; Mohan M; Hou Z; Wang J
Oncotarget; 2016 Mar; 7(9):10271-82. PubMed ID: 26848531
[TBL] [Abstract][Full Text] [Related]
3. Allicin Inhibits Proliferation and Invasion in Vitro and in Vivo via SHP-1-Mediated STAT3 Signaling in Cholangiocarcinoma.
Chen H; Zhu B; Zhao L; Liu Y; Zhao F; Feng J; Jin Y; Sun J; Geng R; Wei Y
Cell Physiol Biochem; 2018; 47(2):641-653. PubMed ID: 29794468
[TBL] [Abstract][Full Text] [Related]
4. Emodin potentiates the anticancer effect of cisplatin on gallbladder cancer cells through the generation of reactive oxygen species and the inhibition of survivin expression.
Wang W; Sun Y; Li X; Li H; Chen Y; Tian Y; Yi J; Wang J
Oncol Rep; 2011 Nov; 26(5):1143-8. PubMed ID: 21769433
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of verapamil-enhanced chemosensitivity of gallbladder cancer cells to platinum drugs: glutathione reduction and MRP1 downregulation.
Wang H; Li X; Chen T; Wang W; Liu Q; Li H; Yi J; Wang J
Oncol Rep; 2013 Feb; 29(2):676-84. PubMed ID: 23229154
[TBL] [Abstract][Full Text] [Related]
6. Luteolin selectively kills STAT3 highly activated gastric cancer cells through enhancing the binding of STAT3 to SHP-1.
Song S; Su Z; Xu H; Niu M; Chen X; Min H; Zhang B; Sun G; Xie S; Wang H; Gao Q
Cell Death Dis; 2017 Feb; 8(2):e2612. PubMed ID: 28182003
[TBL] [Abstract][Full Text] [Related]
7. Activation of the nuclear receptor FXR enhances hepatocyte chemoprotection and liver tumor chemoresistance against genotoxic compounds.
Vaquero J; Briz O; Herraez E; Muntané J; Marin JJ
Biochim Biophys Acta; 2013 Oct; 1833(10):2212-9. PubMed ID: 23680185
[TBL] [Abstract][Full Text] [Related]
8. Repression of GRIM19 expression potentiates cisplatin chemoresistance in advanced bladder cancer cells via disrupting ubiquitination-mediated Bcl-xL degradation.
Ni F; Yan CY; Zhou S; Hui PY; Du YH; Zheng L; Yu J; Hu XJ; Zhang ZG
Cancer Chemother Pharmacol; 2018 Oct; 82(4):593-605. PubMed ID: 30032449
[TBL] [Abstract][Full Text] [Related]
9. Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathway.
Ren T; Shan J; Qing Y; Qian C; Li Q; Lu G; Li M; Li C; Peng Y; Luo H; Zhang S; Zhang W; Wang D; Zhou SF
Drug Des Devel Ther; 2014; 8():2517-29. PubMed ID: 25548514
[TBL] [Abstract][Full Text] [Related]
10. Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3.
Chen KF; Chen HL; Liu CY; Tai WT; Ichikawa K; Chen PJ; Cheng AL
Biochem Pharmacol; 2012 Mar; 83(6):769-77. PubMed ID: 22230479
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic implication of HER2 in advanced biliary tract cancer.
Nam AR; Kim JW; Cha Y; Ha H; Park JE; Bang JH; Jin MH; Lee KH; Kim TY; Han SW; Im SA; Kim TY; Oh DY; Bang YJ
Oncotarget; 2016 Sep; 7(36):58007-58021. PubMed ID: 27517322
[TBL] [Abstract][Full Text] [Related]
12. Arctigenin enhances chemosensitivity of cancer cells to cisplatin through inhibition of the STAT3 signaling pathway.
Yao X; Zhu F; Zhao Z; Liu C; Luo L; Yin Z
J Cell Biochem; 2011 Oct; 112(10):2837-49. PubMed ID: 21608020
[TBL] [Abstract][Full Text] [Related]
13. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
Noh K; Kim YM; Kim YW; Kim SG
Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890
[TBL] [Abstract][Full Text] [Related]
14. GW4064 enhances the chemosensitivity of colorectal cancer to oxaliplatin by inducing pyroptosis.
Guo J; Zheng J; Mu M; Chen Z; Xu Z; Zhao C; Yang K; Qin X; Sun X; Yu J
Biochem Biophys Res Commun; 2021 Apr; 548():60-66. PubMed ID: 33631675
[TBL] [Abstract][Full Text] [Related]
15. Morin inhibits STAT3 tyrosine 705 phosphorylation in tumor cells through activation of protein tyrosine phosphatase SHP1.
Gupta SC; Phromnoi K; Aggarwal BB
Biochem Pharmacol; 2013 Apr; 85(7):898-912. PubMed ID: 23279849
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Leydig tumor growth by farnesoid X receptor activation: the in vitro and in vivo basis for a novel therapeutic strategy.
Catalano S; Panza S; Malivindi R; Giordano C; Barone I; Bossi G; Lanzino M; Sirianni R; Mauro L; Sisci D; Bonofiglio D; Andò S
Int J Cancer; 2013 May; 132(10):2237-47. PubMed ID: 23124354
[TBL] [Abstract][Full Text] [Related]
17. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.
Rajendran P; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Ahn KS; Kumar AP; Sethi G
J Cell Physiol; 2012 May; 227(5):2184-95. PubMed ID: 21792937
[TBL] [Abstract][Full Text] [Related]
18. Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells.
Liu CY; Su JC; Ni MH; Tseng LM; Chu PY; Wang DS; Tai WT; Kao YP; Hung MH; Shiau CW; Chen KF
Breast Cancer Res Treat; 2014 Jul; 146(1):71-84. PubMed ID: 24903225
[TBL] [Abstract][Full Text] [Related]
19. Farnesoid X receptor ligand prevents cisplatin-induced kidney injury by enhancing small heterodimer partner.
Bae EH; Choi HS; Joo SY; Kim IJ; Kim CS; Choi JS; Ma SK; Lee J; Kim SW
PLoS One; 2014; 9(1):e86553. PubMed ID: 24475141
[TBL] [Abstract][Full Text] [Related]
20. Relevance of FXR-p62/SQSTM1 pathway for survival and protection of mouse hepatocytes and liver, especially with steatosis.
Haga S; Yimin ; Ozaki M
BMC Gastroenterol; 2017 Jan; 17(1):9. PubMed ID: 28086800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
